GSK SYLVER 221971

You are invited to participate in the GSK SYLVER 221971 study.

his application is intended to support a clinical research trial by Glaxo Smith Kline This application allows patients in the GSK SYLVER 221971 clinical trial to adhere to a visit schedule and submit information.

Trained healthcare providers working at research sites will invite participants who use this application. They will use the application to collect information using various Research Kit tasks.

This application is not being used by one specific business or organisation. The application is being utilised to conduct a decentralised clinical trial by various independent clinics and hospital networks in order to work with a large patient population.

This application, GSK 219685, is not intended to be used (nor able to be used) on an iPad. Please be careful when entering the email and password.